Premium
P4‐293: COMPARISON OF FLORTAUCIPIR PET WITH CEREBROSPINAL FLUID, COGNITIVE FUNCTIONING AND NEUROIMAGING MEASURES IN MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE
Author(s) -
Okafor Maureen O.,
Nye Jonathon,
Shokouhi Mahsa,
Shaw Leslie M.,
Goldstein Felicia C.,
Hajjar Ihab
Publication year - 2019
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2019.06.3962
Subject(s) - cerebrospinal fluid , standardized uptake value , neuroimaging , neuropsychology , alzheimer's disease neuroimaging initiative , positron emission tomography , psychology , medicine , cognition , cognitive impairment , alzheimer's disease , nuclear medicine , oncology , neuroscience , disease
P4-293 COMPARISON OF FLORTAUCIPIR PET WITH CEREBROSPINAL FLUID, COGNITIVE FUNCTIONING AND NEUROIMAGING MEASURES IN MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER’S DISEASE Maureen O. Okafor, Jonathon Nye, Mahsa Shokouhi, Leslie M. Shaw, Felicia C. Goldstein, Ihab Hajjar, Emory University, Atlanta, GA, USA; Center for Neurodegenerative Disease Research, University of Pennsylvania, Philadelphia, PA, USA. Contact e-mail: m.o.okafor@ emory.edu